Novaccess Global Stock Analysis
| XSNX Stock | USD 0.01 0 80.00% |
NovAccess Global is fairly valued with Real Value of 0.00925 and Hype Value of 0.01. The main objective of NovAccess Global pink sheet analysis is to determine its intrinsic value, which is an estimate of what NovAccess Global is worth, separate from its market price. There are two main types of NovAccess Global's stock analysis: fundamental analysis and technical analysis.
The NovAccess Global pink sheet is traded in the USA on PINK Exchange, with the market opening at 09:30:00 and closing at 16:00:00 every Mon,Tue,Wed,Thu,Fri except for officially observed holidays in the USA.
NovAccess |
NovAccess Pink Sheet Analysis Notes
About 53.0% of the company outstanding shares are owned by insiders. The company recorded a loss per share of 0.24. NovAccess Global last dividend was issued on the 26th of August 2020. The entity had 1:1000 split on the 26th of August 2020. NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.The quote for NovAccess Global is published daily by the National Quotation Bureau and the company does not need to meet minimum requirements or file with the SEC. For more information please call MPH MPH at 440 644 1027 or visit https://novaccessglobal.com.NovAccess Global Investment Alerts
| NovAccess Global is way too risky over 90 days horizon | |
| NovAccess Global has some characteristics of a very speculative penny stock | |
| NovAccess Global appears to be risky and price may revert if volatility continues | |
| NovAccess Global currently holds 165.88 K in liabilities. NovAccess Global has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist NovAccess Global until it has trouble settling it off, either with new capital or with free cash flow. So, NovAccess Global's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like NovAccess Global sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for NovAccess to invest in growth at high rates of return. When we think about NovAccess Global's use of debt, we should always consider it together with cash and equity. | |
| Net Loss for the year was (1.72 M) with profit before overhead, payroll, taxes, and interest of 752.56 K. | |
| NovAccess Global currently holds about 89.94 K in cash with (903.49 K) of positive cash flow from operations. | |
| Roughly 53.0% of the company outstanding shares are owned by insiders |
NovAccess Market Capitalization
The company currently falls under 'Nano-Cap' category with a current market capitalization of 4.11 M. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate NovAccess Global's market, we take the total number of its shares issued and multiply it by NovAccess Global's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities.Technical Drivers
As of the 4th of December, NovAccess Global secures the Mean Deviation of 14.74, downside deviation of 26.81, and Risk Adjusted Performance of 0.0982. In connection with fundamental indicators, the technical analysis model lets you check existing technical drivers of NovAccess Global, as well as the relationship between them.NovAccess Global Price Movement Analysis
The output start index for this execution was thirteen with a total number of output elements of fourty-eight. The Bollinger Bands is very popular indicator that was developed by John Bollinger. It consist of three lines. NovAccess Global middle band is a simple moving average of its typical price. The upper and lower bands are (N) standard deviations above and below the middle band. The bands widen and narrow when the volatility of the price is higher or lower, respectively. The upper and lower bands can also be interpreted as price targets for NovAccess Global. When the price bounces off of the lower band and crosses the middle band, then the upper band becomes the price target.
NovAccess Global Outstanding Bonds
NovAccess Global issues bonds to finance its operations. Corporate bonds make up one of the largest components of the U.S. bond market, which is considered the world's largest securities market. NovAccess Global uses the proceeds from bond sales for a wide variety of purposes, including financing ongoing mergers and acquisitions, buying new equipment, investing in research and development, buying back their own stock, paying dividends to shareholders, and even refinancing existing debt. Most NovAccess bonds can be classified according to their maturity, which is the date when NovAccess Global has to pay back the principal to investors. Maturities can be short-term, medium-term, or long-term (more than ten years). Longer-term bonds usually offer higher interest rates but may entail additional risks.
| US670001AG19 Corp BondUS670001AG19 | View | |
| US670001AH91 Corp BondUS670001AH91 | View | |
| Novelis Corp 475 Corp BondUS670001AE60 | View | |
| Dana 575 percent Corp BondUS235822AB96 | View | |
| Boeing Co 2196 Corp BondUS097023DG73 | View | |
| BNP Paribas FRN Corp BondUSF1R15XK367 | View | |
| AerCap Global Aviation Corp BondUS00773HAA59 | View |
NovAccess Global Predictive Daily Indicators
NovAccess Global intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of NovAccess Global pink sheet daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
NovAccess Global Forecast Models
NovAccess Global's time-series forecasting models are one of many NovAccess Global's pink sheet analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary NovAccess Global's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.About NovAccess Pink Sheet Analysis
Pink Sheet analysis is the technique used by a trader or investor to examine and evaluate how NovAccess Global prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling NovAccess shares will generate the highest return on investment. We also built our pink sheet analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Pink Sheet such as NovAccess Global. By using and applying NovAccess Pink Sheet analysis, traders can create a robust methodology for identifying NovAccess entry and exit points for their positions.
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio. Novaccess Global operates under Biotechnology classification in the United States and is traded on OTC Exchange. It employs 2 people.
Be your own money manager
As an investor, your ultimate goal is to build wealth. Optimizing your investment portfolio is an essential element in this goal. Using our pink sheet analysis tools, you can find out how much better you can do when adding NovAccess Global to your portfolios without increasing risk or reducing expected return.Did you try this?
Run Positions Ratings Now
Positions RatingsDetermine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |
| All Next | Launch Module |
Additional Tools for NovAccess Pink Sheet Analysis
When running NovAccess Global's price analysis, check to measure NovAccess Global's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy NovAccess Global is operating at the current time. Most of NovAccess Global's value examination focuses on studying past and present price action to predict the probability of NovAccess Global's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move NovAccess Global's price. Additionally, you may evaluate how the addition of NovAccess Global to your portfolios can decrease your overall portfolio volatility.